2001 was a mixed year for health care manufacturers, characterized by real advances in cardiac devices, the maturing of the biotech and generic sectors, and an embattled Big Pharma.
1) September11th. Once it had gotten over the immediate shock of the attacks, the health care industry woke up both...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?